Acutaas Chemicals Board Approves Q2 FY27 Standalone & Consolidated Results
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 27 Oct 2026, 12:40 PM IST · BSE ID: aab66990-5f7c-4b1f-aba5-0336f55fffec
View Original BSE Filing (PDF)
⚡ Quick Answer
Acutaas Chemicals Ltd's Board of Directors on October 27, 2026, approved the Unaudited Standalone & Consolidated Financial Results for the Q2 and Half Year ending September 30, 2026. The Audit Committee reviewed these results before the board's approval. M/s Maheshwari & Co. provided the Limited Review Report.
💡
In Simple Terms
The company's board has approved its financial performance report for the second quarter and first half of the current financial year.
🤖 AI Summary
- Acutaas Chemicals Board approved Unaudited Standalone and Consolidated Financial Results for Q2 FY27.
- The results cover the second quarter and half year ended September 30, 2026.
- Audit Committee reviewed and recommended the financial results to the Board.
- M/s Maheshwari & Co., Chartered Accountants, issued the Limited Review Report.
- The Board Meeting commenced at 11:30 A.M. and concluded at 2:35 P.M.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this administrative filing.
👤
Who Is Affected
All shareholders are affected as the company has formally approved and will disseminate its Q2 FY27 financial performance, impacting their understanding of company value.
🔍
Management Signal
The decision to approve results signals adherence to regulatory disclosure timelines and corporate governance processes by the management.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Acutaas Chemicals detailed financial statements for Q2 FY27 — review specific numbers.
Press release accompanying detailed results — for management commentary.
Analyst calls or investor presentations — for further insights into performance.
LOW RISK
This filing is an administrative announcement of results approval, not introducing new risks.
💡 Investor Takeaway
Acutaas Chemicals Ltd Board of Directors approved the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026, on October 27, 2026. This administrative step formalizes the Q2 FY27 results.
📅 Company Track Record
Acutaas Chemicals' Q2 FY27 PAT was reported up 71.4% YoY to ₹1,231mn (consolidated) and standalone net profit rose 17.63% YoY to Rs. 8,573.85 Lakhs (Q2 FY27). Q1 FY27 consolidated net profit was Rs. 7,497.24 lakhs, up 68.30% YoY.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial period do Acutaas Chemicals' approved results cover?
The approved results for Acutaas Chemicals Ltd cover the Unaudited Standalone and Consolidated Financial Results for the second quarter and half year ended September 30, 2026.
Which committee reviewed Acutaas Chemicals' financial results before the board approved them?
The financial results for Acutaas Chemicals Ltd were reviewed and recommended by the Audit Committee before being presented to the Board of Directors for approval.
Who issued the Limited Review Report for Acutaas Chemicals' financial results?
The Statutory Auditors, M/s Maheshwari & Co., issued the Limited Review Report for the Unaudited Standalone & Consolidated Financial Results of Acutaas Chemicals Ltd.
When did the Board of Directors of Acutaas Chemicals Ltd meet to approve financial results?
The Board of Directors of Acutaas Chemicals Ltd met on Friday, October 27, 2026, to consider and approve the Unaudited Standalone & Consolidated Financial Results.
Questions based on this BSE filing only. For information purposes.